Blood plasma from Covid-19 survivors ‘improved symptoms of severely ill patients’

Scientists in China who conducted the preliminary study said no serious adverse reactions were observed after the transfusion.

A single dose of antibodies drawn from the blood of Covid-19 survivors appears to have improved the symptoms of 10 patients severely ill with the disease, according to new research.

The treatment, known as convalescent plasma (CP) therapy, involves using antibody-rich blood plasma of those who have recovered from coronavirus, which can neutralise the bug to fight infection.